The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Feliza Mirasol is the science editor for 

Articles

Sarepta Therapeutics received expanded approval from FDA for Elevidys in the treatment of DMD in non-ambulatory patients as ell as ambulatory patients.

Sarepta’s Elevidys for Duchenne Muscular Dystrophy Gets Expanded FDA Approval

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Podcasts

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish 

A new initiative will advance access to quality medicines and vaccines in Africa.

USP and African Institutions Provide Free Access to Pharma Production Resources

The companies have completed the expansion and qualification phase and now enter a stand-by phase for five years.

CordenPharma and WACKER Consortium Enters Pandemic Readiness

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

The $58 million investment has resulted in a 72,000-square-foot facility with a dedicated LC–MS space and molecular suites and will bring as many as 350 new jobs onto the campus.

Thermo Fisher Opens New Building at Wisconsin GMP Lab

Yimmugo, which was introduced in Europe at the end of 2022, could be on the market in the US within months.

FDA Approves Immunoglobulin Therapeutic to Treat Primary Immunodeficiencies

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview. 

The Benefit of Long-Read Sequencing in Gene Therapies

John Bertagnolli, vice-president of Commercial Operations at Selkirk Pharma, discusses considerations when building and scaling up pharmaceutical facilities, including contamination control and aseptic processing challenges.

Considerations in Pharmaceutical Facility Design (CPHI North America 2024)

Ecolab Life Sciences and Repligen have launched a new affinity resin, DurA Cycle, for large-scale biologics manufacturing.

New Affinity Resin Launched by Ecolab Life Sciences and Repligen for Biologics Manufacturing

Krizia M. Karry, PhD, ishead of Global Technical Marketing, Pharma Solutions, BASF.

Brian Carlin is president and owner of Carlin Pharma Consulting LLC.

Nigel Langley, PhD, MBA, is global technical director at Gaylord Life Sciences and Immediate Past Chair, IPEC- Americas.

R. Christian Moreton, PhD, is vice-president of pharmaceutical sciences at Finnbrit Consulting and a member of Pharmaceutical Technology’s editorial advisory board.

David Schoneker is president, Black Diamond Regulatory Consulting, LLC

Katherine L. Ulman is president of KLU Consulting.

Joseph Zeleznik is technical product director, IMCD US

Key information is needed for excipients and their potential impact on continuous manufacturing processes.